We also used the TIDE algorithm and ESTIMATE algorithm to compare the relevant differences in the tumor immune microenvironment between the two MAP2K3 expression levels to quantify the association between MAP2K3 expression levels and potential immunotherapeutic effects. Here, MAP2K3 is linked to neoplasm.